AKT1 and acute lymphoblastic leukemia: The normal expression of PTEN and the lack of detectable AKT phosphorylation in non-malignant whole thymocytes suggest that use of AKT inhibitors in T-ALL therapy could largely preserve the healthy hematopoietic population.